Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancerE Angevin, D Valteau-Couanet, F Farace, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|May 1, 1984
[Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer]T Shibayama, M Nakazono, Y Koyama, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|November 1, 1989
[Long-term results of M-VAC for the treatment of advanced urothelial cancer]M Tachibana, T Iigaya, T Shibayama, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1989
[Comparative study on prophylactic intravesical instillation of bacillus Calmette-Guerin (BCG) and adriamycin for superficial bladder cancers]M Tachibana, S Jitsukawa, T Iigaya, et al.
Science (New York, N.Y.)|June 28, 1985
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clonesJ Ritz, T J Campen, R E Schmidt, et al.
Cellular Immunology|July 1, 1984
Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structureT Hercend, S Meuer, A Brennan, et al.
The Journal of Experimental Medicine|September 1, 1986
Sequences and diversity of human T cell receptor beta chain variable region genesN Kimura, B Toyonaga, Y Yoshikai, et al.
Experimental Hematology|July 1, 1979
Trochanter bone marrow: a source of normal human colony forming cellsP G de Laforest, B Rio, F Triebel, et al.
The Journal of Experimental Medicine|November 1, 1983
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector functionT Hercend, S Meuer, A Brennan, et al.
Transplantation|September 1, 1986
Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantationL Delmon, A Ythier, P Moingeon, et al.
Pageof 28